RJA
MDT icon

Raymond James & Associates’s Medtronic MDT Stock Holding History

Raymond James & Associates’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-14,500
Closed -$12.6K – 3984
2022
Q4 		$12.6K Sell
14,500
-30,400
-68% -$2.46M ﹤0.01% 3835
2022
Q3 		$19K Sell
44,900
-600
-1% -$53.9K ﹤0.01% 3804
2022
Q2 		$26K Sell
45,500
-3,500
-7% -$355K ﹤0.01% 3856
2022
Q1 		$32K Sell
49,000
-1,800
-4% -$190K ﹤0.01% 3954
2021
Q4 		$19K Sell
50,800
-3,100
-6% -$359K ﹤0.01% 4031
2021
Q3 		$32K Buy
53,900
+11,100
+26% +$1.44M ﹤0.01% 3959
2021
Q2 		$40K Sell
42,800
-16,900
-28% -$2.12M ﹤0.01% 3933
2021
Q1 		$36K Buy
59,700
+6,100
+11% +$715K ﹤0.01% 3876
2020
Q4 		$57K Sell
53,600
-20,500
-28% -$2.26M ﹤0.01% 3615
2020
Q3 		$117K Buy
74,100
+27,000
+57% +$2.71M ﹤0.01% 3356
2020
Q2 		$6K Sell
47,100
-14,000
-23% -$1.34M ﹤0.01% 3494
2020
Q1 		$19K Sell
61,100
-42,000
-41% -$4.47M ﹤0.01% 3403
2019
Q4 		$160K Buy
103,100
+20,100
+24% +$2.21M ﹤0.01% 3408
2019
Q3 		$246K Sell
83,000
-20,300
-20% -$2.12M ﹤0.01% 3127
2019
Q2 		$63K Buy
+103,300
New +$9.43M ﹤0.01% 3477
2017
Q3 		– Sell
-35,100
Closed -$235K – 3462
2017
Q2 		$235K Sell
35,100
-40,100
-53% -$3.38M ﹤0.01% 2887
2017
Q1 		$163K Sell
75,200
-800
-1% -$62.5K ﹤0.01% 2979
2016
Q4 		$2K Sell
76,000
-25,100
-25% -$1.97M ﹤0.01% 3221
2016
Q3 		$367K Buy
101,100
+84,800
+520% +$7.39M ﹤0.01% 2487
2016
Q2 		$51K Buy
+16,300
New +$1.32M ﹤0.01% 2869

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Raymond James & Associates's MDT Position: Q3 2024 in Review

Raymond James & Associates increased its Medtronic (MDT) stake by 2.3% in Q3 2024, buying an estimated $12.2M and bringing the position to 6,391,865 shares worth $575M. The position accounts for 0.35% of the portfolio, ranked #53.

Raymond James & Associates first reported a position in MDT in Q2 2013 and has held it in 46 quarters since. 2,063 funds tracked by Wall St. Rank hold MDT as of Q3 2024.

  • Raymond James & Associates held 6,391,865 shares of Medtronic worth $575M as of Q3 2024.
  • Raymond James & Associates bought 145,504 Medtronic shares in Q3 2024, an estimated $12.2M.
  • Medtronic made up 0.35% of Raymond James & Associates's portfolio in Q3 2024, its #53 holding.
  • Raymond James & Associates first reported a position in Medtronic in Q2 2013 and has held it in 46 quarters since.
  • 2,063 funds tracked by Wall St. Rank held Medtronic as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.